{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:21Z","timestamp":1792788741943,"version":"4.5.0"},"reference-count":165,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH\/NIDDK","award":["R01-DK124138, R01-DK122767, R01-DK132869, and R01-DK132875"],"award-info":[{"award-number":["R01-DK124138, R01-DK122767, R01-DK132869, and R01-DK132875"]}]},{"name":"NIH\/NIDDK","award":["R01-MD013818 and R01-AG071803"],"award-info":[{"award-number":["R01-MD013818 and R01-AG071803"]}]},{"name":"NIH\/NIDDK","award":["R01-MD016961, R01-DK113298, R01DK123104, R01-DK126373, and R01-DK124379"],"award-info":[{"award-number":["R01-MD016961, R01-DK113298, R01DK123104, R01-DK126373, and R01-DK124379"]}]},{"name":"Patient-Centered Outcomes Research Institute","award":["DI-2022C3-30393"],"award-info":[{"award-number":["DI-2022C3-30393"]}],"id":[{"id":"https:\/\/ror.org\/014q65q44","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This year commemorates the 75th anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the 27 institutes and centers of the National Institutes of Health. A core mission of the NIDDK has been the advancement and support of biomedical research across a diverse spectrum of disciplines, including endocrine and metabolic diseases, digestive and nutritional disorders, obesity, urologic and benign hematologic conditions, and, notably, kidney diseases, which has been a major focus of the institute's strategic priorities. Through the years, the NIDDK has heavily invested in biomedical infrastructure, foundational studies, and cross-cutting basic science, clinical investigation, epidemiology, and health services research, which have fundamentally shaped the detection, management, and prevention of kidney diseases worldwide. Furthermore, the NIDDK has had a longstanding commitment to promoting workforce development, advancing equal access to kidney health care, and forging collaborative partnerships with academic centers, federal agencies, professional societies, patient advocacy organizations, community groups, and industry stakeholders toward the shared goal of improving kidney disease outcomes. In this review published across the three American Society of Nephrology journals, we celebrate the landmark achievements and profound effect of the NIDDK in improving the health and well-being of people living with kidney diseases worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000906","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:03:45Z","timestamp":1759248225000},"page":"883-896","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Commemorating the National Institute of Diabetes and Digestive and Kidney Diseases' Advances in Kidney Health"],"prefix":"10.2215","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-6469","authenticated-orcid":false,"given":"Connie M.","family":"Rhee","sequence":"first","affiliation":[{"name":"Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California"},{"name":"Nephrology Section, VA Greater Los Angeles Healthcare System, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Allon","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2833-067X","authenticated-orcid":false,"given":"Rajnish","family":"Mehrotra","sequence":"additional","affiliation":[{"name":"Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"1","key":"B5-20261023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.2012080800","article-title":"Temporal changes in incidence of dialysis-requiring AKI","volume":"24","author":"Hsu","year":"2013","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B7-20261023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/joneph\/17.1.159","article-title":"Homer W. Smith's contribution to renal physiology","volume":"17","author":"Giebisch","year":"2004","journal-title":"J Nephrol."},{"issue":"8","key":"B8-20261023","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1172\/JCI23150","article-title":"The legacy of Homer W. Smith: mechanistic insights into renal physiology","volume":"114","author":"Navar","year":"2004","journal-title":"J Clin Invest."},{"issue":"9","key":"B9-20261023","first-page":"e69098","article-title":"Dr. Willem Kolff: The father of the artificial kidney","volume":"16","author":"Sharma","year":"2024","journal-title":"Cureus."},{"issue":"1","key":"B10-20261023","first-page":"55","article-title":"Medicare's end stage renal disease program","volume":"22","author":"Eggers","year":"2000","journal-title":"Health Care Financ Rev."},{"issue":"9","key":"B11-20261023","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2215\/CJN.0000000000000512","article-title":"Comparing medicare fee-for-service beneficiaries with ESKD who switched to medicare advantage versus remained in traditional medicare","volume":"19","author":"Gao","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"12","key":"B12-20261023","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2215\/CJN.0000000000000560","article-title":"Sudden Cardiac death reporting in US patients on dialysis: comparison of United States renal data system and national death Index data","volume":"19","author":"Obi","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"15","key":"B13-20261023","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1113\/JP271904","article-title":"Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice","volume":"594","author":"Sala-Rabanal","year":"2016","journal-title":"J Physiol."},{"issue":"3","key":"B14-20261023","doi-asserted-by":"crossref","first-page":"C348","DOI":"10.1152\/ajpcell.00115.2012","article-title":"Regulation of the human Na+-dependent glucose cotransporter hSGLT2","volume":"303","author":"Ghezzi","year":"2012","journal-title":"Am J Physiol Cell Physiol."},{"issue":"1","key":"B15-20261023","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00388.2010","article-title":"Glucose transport by human renal Na+\/D-glucose cotransporters SGLT1 and SGLT2","volume":"300","author":"Hummel","year":"2011","journal-title":"Am J Physiol Cell Physiol."},{"issue":"2","key":"B16-20261023","doi-asserted-by":"crossref","first-page":"C373","DOI":"10.1152\/ajpcell.00328.2011","article-title":"Structural selectivity of human SGLT inhibitors","volume":"302","author":"Hummel","year":"2012","journal-title":"Am J Physiol Cell Physiol."},{"issue":"6","key":"B17-20261023","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2012.170","article-title":"Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury","volume":"82","author":"Luther","year":"2012","journal-title":"Kidney Int."},{"issue":"6","key":"B18-20261023","doi-asserted-by":"crossref","first-page":"F1287","DOI":"10.1152\/ajprenal.00017.2008","article-title":"Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells","volume":"294","author":"Huang","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"issue":"4","key":"B19-20261023","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0002-9440(10)63486-4","article-title":"Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(\u2212\/\u2212) mice","volume":"163","author":"Ma","year":"2003","journal-title":"Am J Pathol."},{"issue":"1","key":"B20-20261023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gene.2013.08.047","article-title":"Aldosterone stimulates fibronectin synthesis in renal fibroblasts through mineralocorticoid receptor-dependent and independent mechanisms","volume":"531","author":"Chen","year":"2013","journal-title":"Gene."},{"issue":"23","key":"B21-20261023","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med."},{"issue":"6","key":"B22-20261023","doi-asserted-by":"crossref","first-page":"F1341","DOI":"10.1152\/ajprenal.00527.2019","article-title":"Effects of extreme potassium stress on blood pressure and renal tubular sodium transport","volume":"318","author":"Boyd-Shiwarski","year":"2020","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6455","key":"B23-20261023","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature."},{"issue":"10","key":"B24-20261023","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med."},{"issue":"1","key":"B25-20261023","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B26-20261023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","article-title":"Aquaporins in the kidney: from molecules to medicine","volume":"82","author":"Nielsen","year":"2002","journal-title":"Physiol Rev."},{"issue":"5","key":"B27-20261023","doi-asserted-by":"crossref","first-page":"F965","DOI":"10.1152\/ajprenal.00085.2003","article-title":"Effect of primary polydipsia on aquaporin and sodium transporter abundance","volume":"285","author":"Cadnapaphornchai","year":"2003","journal-title":"Am J Physiol Renal Physiol."},{"issue":"36","key":"B28-20261023","doi-asserted-by":"crossref","first-page":"24617","DOI":"10.1074\/jbc.M803074200","article-title":"Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2","volume":"283","author":"Hoffert","year":"2008","journal-title":"J Biol Chem."},{"issue":"2","key":"B29-20261023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1681\/ASN.V122207","article-title":"Increased abundance of distal sodium transporters in rat kidney during vasopressin escape","volume":"12","author":"Ecelbarger","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"24","key":"B30-20261023","doi-asserted-by":"crossref","first-page":"e161765","DOI":"10.1172\/jci.insight.161765","article-title":"Kidney collecting duct cells make vasopressin in response to NaCl-induced hypertonicity","volume":"7","author":"Arroyo","year":"2022","journal-title":"JCI Insight."},{"issue":"5","key":"B31-20261023","doi-asserted-by":"crossref","first-page":"F553","DOI":"10.1152\/ajprenal.00438.2011","article-title":"Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin","volume":"304","author":"Bouley","year":"2013","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"B32-20261023","doi-asserted-by":"crossref","first-page":"C38","DOI":"10.1152\/ajpcell.00109.2012","article-title":"Basolateral targeting and microtubule-dependent transcytosis of the aquaporin-2 water channel","volume":"304","author":"Yui","year":"2013","journal-title":"Am J Physiol Cell Physiol."},{"issue":"25","key":"B33-20261023","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med."},{"issue":"20","key":"B34-20261023","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med."},{"issue":"9","key":"B35-20261023","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2013090976","article-title":"Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS","volume":"25","author":"Gbadegesin","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"B36-20261023","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1172\/JCI46458","article-title":"Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis","volume":"121","author":"Akilesh","year":"2011","journal-title":"J Clin Invest."},{"issue":"4","key":"B37-20261023","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0002-9440(10)63228-2","article-title":"Differential expression of d-type cyclins in podocytes in vitro and in vivo","volume":"164","author":"Petermann","year":"2004","journal-title":"Am J Pathol."},{"issue":"1","key":"B38-20261023","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1523-1755.2003.00723.x","article-title":"Mitotic cell cycle proteins increase in podocytes despite lack of proliferation","volume":"63","author":"Petermann","year":"2003","journal-title":"Kidney Int."},{"issue":"10","key":"B39-20261023","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1681\/ASN.2009121253","article-title":"Activation of NFAT signaling in podocytes causes glomerulosclerosis","volume":"21","author":"Wang","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B40-20261023","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","article-title":"The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A","volume":"14","author":"Faul","year":"2008","journal-title":"Nat Med."},{"issue":"2","key":"B41-20261023","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.0000000581","article-title":"Xenotransplantation: the future is here","volume":"36","author":"Riella","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"B42-20261023","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1681\/ASN.0000000745","article-title":"Xenotransplantation: current understanding of the mechanism of immune-mediated injury","volume":"36","author":"Tatapudi","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"13","key":"B43-20261023","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med."},{"issue":"6","key":"B44-20261023","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med."},{"issue":"9","key":"B45-20261023","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"12","key":"B46-20261023","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1681\/ASN.2021070988","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"32","author":"Delgado","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B47-20261023","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"21","key":"B48-20261023","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA."},{"issue":"7 suppl 2","key":"B49-20261023","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/01.ASN.0000070149.78399.CE","article-title":"The chronic renal insufficiency cohort (CRIC) study: design and methods","volume":"14","author":"Feldman","year":"2003","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B50-20261023","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2215\/CJN.0000000676","article-title":"Defining kidney health dimensions and their associations with adverse outcomes in persons with diabetes and CKD","volume":"20","author":"Peschard","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B51-20261023","doi-asserted-by":"crossref","first-page":"900","DOI":"10.34067\/KID.0000000000000439","article-title":"Health-related social needs during the COVID-19 pandemic: the chronic renal insufficiency cohort (CRIC) study","volume":"5","author":"Novick","year":"2024","journal-title":"Kidney360."},{"key":"B52-20261023","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1681\/ASN.0000000680","article-title":"Clonal hematopoiesis of indeterminate potential and progression of CKD","volume":"36","author":"Vlasschaert","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B53-20261023","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2215\/CJN.0000000760","article-title":"BP and kidney disease progression in advanced CKD: findings from the chronic renal insufficiency cohort and KoreaN cohort study for outcome in patients with CKD studies","volume":"20","author":"Park","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B54-20261023","doi-asserted-by":"crossref","first-page":"958","DOI":"10.2215\/CJN.0000000711","article-title":"Urine biomarkers for diabetic kidney disease progression in participants of the chronic renal insufficiency cohort study","volume":"20","author":"Schrauben","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B55-20261023","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2215\/CJN.11541114","article-title":"Cross-disciplinary biomarkers research: lessons learned by the CKD biomarkers consortium","volume":"10","author":"Hsu","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B56-20261023","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.34067\/KID.0000000000000183","article-title":"Associations of biomarkers of kidney tubule health, injury, and inflammation with left ventricular hypertrophy in children with CKD","volume":"4","author":"Jiang","year":"2023","journal-title":"Kidney360."},{"issue":"12","key":"B57-20261023","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1681\/ASN.0000000000000459","article-title":"The legacy effect of intensive versus standard BP control on the incidence of needing dialysis or kidney transplantation","volume":"35","author":"Pajewski","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B58-20261023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2215\/CJN.0000000000000335","article-title":"Effect of intensive blood pressure control on kidney outcomes: long-term electronic health record-based post-trial follow-up of SPRINT","volume":"19","author":"Drawz","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B59-20261023","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2215\/CJN.0000000000000406","article-title":"Role of diuretics in cardiovascular events and mortality in systolic blood pressure intervention trial: a post hoc analysis","volume":"19","author":"Bansal","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"22","key":"B60-20261023","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med."},{"issue":"9","key":"B61-20261023","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B62-20261023","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/kisup.2015.2","article-title":"United States renal data system public health surveillance of chronic kidney disease and end-stage renal disease","volume":"5","author":"Collins","year":"2015","journal-title":"Kidney Int Suppl (2011)."},{"issue":"3","key":"B63-20261023","doi-asserted-by":"crossref","first-page":"432","DOI":"10.34067\/KID.0000000681","article-title":"Distinguishing among causes of death for patients with kidney failure on hemodialysis","volume":"6","author":"Tran","year":"2025","journal-title":"Kidney360."},{"issue":"6","key":"B64-20261023","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1681\/ASN.0000000000000336","article-title":"Ondansetron and the risk of sudden cardiac death among individuals receiving maintenance hemodialysis","volume":"35","author":"Ismail","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"25","key":"B65-20261023","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med."},{"issue":"21","key":"B66-20261023","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa0805840","article-title":"Effect of dipyridamole plus aspirin on hemodialysis graft patency","volume":"360","author":"Dixon","year":"2009","journal-title":"N Engl J Med."},{"issue":"18","key":"B67-20261023","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.299.18.2164","article-title":"Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial","volume":"299","author":"Dember","year":"2008","journal-title":"JAMA."},{"issue":"10","key":"B68-20261023","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ki.2011.213","article-title":"The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial","volume":"80","author":"Rocco","year":"2011","journal-title":"Kidney Int."},{"issue":"24","key":"B69-20261023","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1056\/NEJMoa1001593","article-title":"In-center hemodialysis six times per week versus three times per week","volume":"363","author":"Chertow","year":"2010","journal-title":"N Engl J Med."},{"issue":"5","key":"B70-20261023","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1681\/ASN.2018090945","article-title":"The TiME trial: a fully embedded, cluster-randomized, pragmatic trial of hemodialysis session duration","volume":"30","author":"Dember","year":"2019","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B71-20261023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.ajkd.2013.06.024","article-title":"Objectives and design of the hemodialysis fistula maturation study","volume":"63","author":"Dember","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"B72-20261023","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2215\/CJN.0000000775","article-title":"Fall risk in maintenance hemodialysis patients: a secondary analysis of the HOPE consortium trial","volume":"20","author":"Charytan","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"B73-20261023","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2215\/CJN.0000000866","article-title":"Patient engagement in the design and conduct of the HOPE Trial: addressing chronic pain in hemodialysis patients","volume":"20","author":"White","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B74-20261023","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamainternmed.2024.7140","article-title":"Pain coping skills training for patients receiving hemodialysis: the HOPE consortium randomized clinical trial","volume":"185","author":"Dember","year":"2025","journal-title":"JAMA Intern Med."},{"issue":"1","key":"B75-20261023","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int."},{"issue":"1","key":"B76-20261023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa0802639","article-title":"Intensity of renal support in critically ill patients with acute kidney injury","volume":"359","author":"Palevsky","year":"2008","journal-title":"N Engl J Med."},{"issue":"7","key":"B77-20261023","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2215\/CJN.0000000000000473","article-title":"Acute kidney injury, systemic inflammation, and long-term cognitive function: ASSESS-AKI","volume":"19","author":"Bhatraju","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B78-20261023","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2021060757","article-title":"Angiopoietins as prognostic markers for future kidney disease and heart failure events after acute kidney injury","volume":"33","author":"Mansour","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B79-20261023","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamainternmed.2019.6390","article-title":"Post-acute kidney injury proteinuria and subsequent kidney disease progression: the assessment, serial evaluation, and subsequent sequelae in acute kidney injury (ASSESS-AKI) study","volume":"180","author":"Hsu","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B80-20261023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2369-11-22","article-title":"The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods","volume":"11","author":"Go","year":"2010","journal-title":"BMC Nephrol."},{"issue":"9","key":"B81-20261023","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.0000000000000393","article-title":"Protein N-glycans in healthy and sclerotic glomeruli in diabetic kidney disease","volume":"35","author":"Velickovic","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B82-20261023","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1681\/ASN.0000000000000358","article-title":"Plasma proteins associated with chronic histopathologic lesions on kidney biopsy","volume":"35","author":"Kim","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B83-20261023","doi-asserted-by":"crossref","first-page":"870","DOI":"10.34067\/KID.0000000000000175","article-title":"Genome-wide association study for AKI","volume":"4","author":"Bhatraju","year":"2023","journal-title":"Kidney360."},{"issue":"2","key":"B84-20261023","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2215\/CJN.0000000000000276","article-title":"Molecular signatures of glomerular neovascularization in a patient with diabetic kidney disease","volume":"19","author":"Ferkowicz","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B85-20261023","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2215\/CJN.0000000000000334","article-title":"Participant experience with protocol research kidney biopsies in the kidney precision medicine project","volume":"19","author":"Victoria-Castro","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B86-20261023","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.kint.2022.02.023","article-title":"Kidney repair and regeneration: perspectives of the NIDDK (Re)building a kidney consortium","volume":"101","author":"Naved","year":"2022","journal-title":"Kidney Int."},{"issue":"25","key":"B87-20261023","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med."},{"issue":"14","key":"B88-20261023","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med."},{"issue":"9131","key":"B89-20261023","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK prospective diabetes study (UKPDS) group","volume":"352","year":"1998","journal-title":"Lancet."},{"issue":"9131","key":"B90-20261023","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group","volume":"352","year":"1998","journal-title":"Lancet."},{"issue":"1","key":"B91-20261023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdiacomp.2003.12.007","article-title":"The family investigation of nephropathy and diabetes (FIND): design and methods","volume":"19","author":"Knowler","year":"2005","journal-title":"J Diabetes Complications."},{"issue":"6","key":"B92-20261023","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J Clin Invest."},{"issue":"2","key":"B93-20261023","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1172\/JCI112013","article-title":"Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass","volume":"76","author":"Anderson","year":"1985","journal-title":"J Clin Invest."},{"issue":"6","key":"B94-20261023","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.trsl.2007.07.001","article-title":"Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats","volume":"150","author":"Komers","year":"2007","journal-title":"Transl Res."},{"issue":"5","key":"B95-20261023","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1067\/mlc.2002.128551","article-title":"Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes","volume":"140","author":"Komers","year":"2002","journal-title":"J Lab Clin Med."},{"issue":"5","key":"B96-20261023","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1681\/ASN.2008070740","article-title":"Activation of the succinate receptor GPR91 in macula densa cells causes renin release","volume":"20","author":"Vargas","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B97-20261023","first-page":"2526","article-title":"Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney","volume":"118","author":"Toma","year":"2008","journal-title":"J Clin Invest."},{"issue":"6","key":"B98-20261023","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/HYPERTENSIONAHA.107.107268","article-title":"The collecting duct is the major source of prorenin in diabetes","volume":"51","author":"Kang","year":"2008","journal-title":"Hypertension."},{"issue":"8","key":"B99-20261023","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/dc11-0476","article-title":"Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control","volume":"34","author":"Harindhanavudhi","year":"2011","journal-title":"Diabetes Care."},{"issue":"1","key":"B100-20261023","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med."},{"issue":"24","key":"B101-20261023","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med."},{"issue":"24","key":"B102-20261023","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"N Engl J Med."},{"issue":"20","key":"B103-20261023","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The collaborative study group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med."},{"issue":"12","key":"B104-20261023","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med."},{"issue":"12","key":"B105-20261023","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med."},{"issue":"4","key":"B106-20261023","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1681\/ASN.2007050556","article-title":"Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics","volume":"19","author":"Wolkow","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B107-20261023","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/db05-1423","article-title":"The 30-year natural history of type 1 diabetes complications: the Pittsburgh epidemiology of diabetes complications study experience","volume":"55","author":"Pambianco","year":"2006","journal-title":"Diabetes"},{"issue":"1","key":"B108-20261023","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1681\/ASN.V71113","article-title":"Evolution of metabolic and renal changes in the ZDF\/Drt-fa rat model of type II diabetes","volume":"7","author":"Vora","year":"1996","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B109-20261023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00579717","article-title":"Renal function in non-insulin-dependent diabetes mellitus: purposes and design of the diabetic renal disease study","volume":"28","author":"Nelson","year":"1991","journal-title":"Acta Diabetol."},{"issue":"1","key":"B110-20261023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0272-6386(89)80105-2","article-title":"Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis, and prevention","volume":"13","author":"FitzSimmons","year":"1989","journal-title":"Am J Kidney Dis."},{"issue":"24","key":"B111-20261023","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med."},{"issue":"15","key":"B112-20261023","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med."},{"issue":"2","key":"B113-20261023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med."},{"issue":"5266","key":"B114-20261023","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science."},{"issue":"2","key":"B115-20261023","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(95)90339-9","article-title":"Polycystic kidney disease: the complete structure of the PKD1 gene and its protein","volume":"81","year":"1995","journal-title":"Cell."},{"issue":"4","key":"B116-20261023","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/hmg\/4.4.575","article-title":"Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 consortium (APKD1 consortium)","volume":"4","author":"Burn","year":"1995","journal-title":"Hum Mol Genet."},{"issue":"5","key":"B117-20261023","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199307293290503","article-title":"The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease","volume":"329","author":"Ye","year":"1993","journal-title":"N Engl J Med."},{"issue":"4","key":"B118-20261023","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B119-20261023","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med."},{"issue":"15","key":"B120-20261023","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1073\/pnas.86.15.6007","article-title":"Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP","volume":"86","author":"Mangoo-Karim","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"B121-20261023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI117638","article-title":"In vitro fluid secretion by epithelium from polycystic kidneys","volume":"95","author":"Grantham","year":"1995","journal-title":"J Clin Invest."},{"issue":"7","key":"B122-20261023","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B123-20261023","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneph.2010.18","article-title":"Molecular diagnostics for autosomal dominant polycystic kidney disease","volume":"6","author":"Harris","year":"2010","journal-title":"Nat Rev Nephrol."},{"issue":"3","key":"B124-20261023","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int."},{"issue":"7","key":"B125-20261023","doi-asserted-by":"crossref","first-page":"648","DOI":"10.34067\/KID.0001692020","article-title":"Interactions between FGF23 and genotype in autosomal dominant polycystic kidney disease","volume":"1","author":"Grau","year":"2020","journal-title":"Kidney360."},{"issue":"6","key":"B126-20261023","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1681\/ASN.0000000613","article-title":"Characterization of the cystic phenotype associated with monoallelic ALG8 and ALG9 pathogenic variants","volume":"36","author":"Jawaid","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B127-20261023","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2215\/CJN.0000000640","article-title":"Overweight status, obesity, and progression to ESKD in patients with autosomal dominant polycystic kidney disease","volume":"20","author":"Nowak","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B129-20261023","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41467-023-37449-1","article-title":"The C-terminal tail of polycystin-1 suppresses cystic disease in a mitochondrial enzyme-dependent fashion","volume":"14","author":"Onuchic","year":"2023","journal-title":"Nat Commun."},{"issue":"1","key":"B130-20261023","doi-asserted-by":"crossref","first-page":"e154773","DOI":"10.1172\/jci.insight.154773","article-title":"The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression","volume":"8","author":"Nguyen","year":"2023","journal-title":"JCI Insight."},{"issue":"1","key":"B131-20261023","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1038\/s41467-024-52363-w","article-title":"Transiently formed nucleus-to-cilium microtubule arrays mediate senescence initiation in a KIFC3-dependent manner","volume":"15","author":"Robichaud","year":"2024","journal-title":"Nat Commun."},{"issue":"1","key":"B132-20261023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12882-024-03685-w","article-title":"Characterizing the impact of the Covid-19 pandemic on adults with autosomal dominant polycystic kidney disease: a cross-sectional study","volume":"25","author":"Shetty","year":"2024","journal-title":"BMC Nephrol."},{"issue":"4","key":"B133-20261023","doi-asserted-by":"crossref","first-page":"F635","DOI":"10.1152\/ajprenal.00013.2024","article-title":"Distinct developmental reprogramming footprint of macrophages during acute kidney injury across species","volume":"326","author":"Mrug","year":"2024","journal-title":"Am J Physiol Renal Physiol."},{"issue":"9","key":"B134-20261023","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1681\/ASN.2010070730","article-title":"The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African americans","volume":"21","author":"Freedman","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"5993","key":"B135-20261023","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science."},{"issue":"11","key":"B136-20261023","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N Engl J Med."},{"issue":"6","key":"B137-20261023","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1681\/ASN.2021060784","article-title":"Molecular characterization of membranous nephropathy","volume":"33","author":"Sealfon","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B138-20261023","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2021101396","article-title":"Kidney biopsy features Most predictive of clinical outcomes in the spectrum of minimal change disease and focal segmental glomerulosclerosis","volume":"33","author":"Zee","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B139-20261023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2215\/CJN.0000000000000309","article-title":"The significance of hematuria in podocytopathies","volume":"19","author":"Marchel","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B140-20261023","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2215\/CJN.0000000597","article-title":"Clinical relevance of computational pathology analysis of interplay between kidney microvasculature and interstitial microenvironment","volume":"20","author":"Chen","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B141-20261023","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the nephrotic syndrome study network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int."},{"issue":"8","key":"B142-20261023","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.34067\/KID.0000000787","article-title":"Clinical significance of immune deposits and complement system activation in FSGS: findings from the cure glomerulonephropathy network study","volume":"6","author":"Caliskan","year":"2025","journal-title":"Kidney360."},{"issue":"10","key":"B143-20261023","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2215\/CJN.0000000000000237","article-title":"Anti-PLA2R antibody levels and clinical risk factors for treatment nonresponse in membranous nephropathy","volume":"18","author":"Barbour","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B144-20261023","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1681\/ASN.0000000653","article-title":"Family history in the context of CKD","volume":"36","author":"Zanoni","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B145-20261023","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2215\/CJN.0000000707","article-title":"Proteinuria trajectory and disease progression in children and adults with IgA nephropathy\/vasculitis","volume":"20","author":"Glenn","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B146-20261023","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2215\/CJN.0000000000000070","article-title":"Kidney disease progression in membranous nephropathy among black participants with high-risk APOL1 genotype","volume":"18","author":"Chen","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B147-20261023","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ajkd.2018.07.020","article-title":"CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease","volume":"73","author":"Mariani","year":"2019","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B148-20261023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med."},{"issue":"12","key":"B149-20261023","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ekir.2019.09.005","article-title":"Treatment patterns among adults and children with membranous nephropathy in the cure glomerulonephropathy network (CureGN)","volume":"4","author":"O'Shaughnessy","year":"2019","journal-title":"Kidney Int Rep."},{"issue":"1","key":"B150-20261023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2215\/CJN.0000000000000318","article-title":"Circulating metabolomic associations with neurocognitive outcomes in pediatric CKD","volume":"19","author":"Lee","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B151-20261023","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1681\/ASN.2022060725","article-title":"Genomic disorders in CKD across the lifespan","volume":"34","author":"Verbitsky","year":"2023","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B152-20261023","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1681\/ASN.0000000602","article-title":"Biomarker panels for discriminating risk of CKD progression in children","volume":"36","author":"Greenberg","year":"2025","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B153-20261023","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2215\/CJN.01941205","article-title":"Design and methods of the chronic kidney disease in children (CKiD) prospective cohort study","volume":"1","author":"Furth","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"B154-20261023","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2337\/dc20-0760","article-title":"Health care coverage and glycemic control in young adults with youth-onset type 2 diabetes: results from the TODAY2 study","volume":"43","year":"2020","journal-title":"Diabetes Care."},{"issue":"12","key":"B155-20261023","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2215\/CJN.0000000000000559","article-title":"Proteomic analysis uncovers multiprotein signatures associated with early diabetic kidney disease in youth with type 2 diabetes mellitus","volume":"19","author":"Pyle","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B156-20261023","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ijo.2009.195","article-title":"Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study","volume":"34","year":"2010","journal-title":"Int J Obes (Lond)."},{"issue":"9","key":"B157-20261023","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2215\/CJN.14741219","article-title":"Reimagining institutional research training: coordinating a highly interactive community of young investigators prepared to excel","volume":"15","author":"Spruance","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"suppl 1","key":"B158-20261023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.18865\/ed.29.S1.119","article-title":"Building the network of minority health research investigators: a novel program to enhance leadership and success of underrepresented minorities in biomedical research","volume":"29","author":"Blanchard","year":"2019","journal-title":"Ethn Dis."},{"issue":"1","key":"B159-20261023","doi-asserted-by":"crossref","first-page":"5","DOI":"10.18865\/ed.30.1.5","article-title":"The NIDDK high school short-term research experience for underrepresented persons","volume":"30","author":"Rivers","year":"2020","journal-title":"Ethn Dis."},{"issue":"8","key":"B160-20261023","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2215\/CJN.03360318","article-title":"Rebuilding the pipeline of investigators in nephrology research in the United States","volume":"13","author":"Norton","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B161-20261023","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2215\/CJN.14260920","article-title":"The influence of medical school debt on career choices in nephrology","volume":"16","author":"Ginsberg","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B162-20261023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajcnut.2024.12.011","article-title":"Increasing diversity in the nutrition, obesity, and diabetes biomedical workforce: the BRIDGES consortium","volume":"121","author":"Newton","year":"2025","journal-title":"Am J Clin Nutr."},{"issue":"12","key":"B163-20261023","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/TP.0b013e318292520e","article-title":"Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis","volume":"95","author":"Nee","year":"2013","journal-title":"Transplantation."},{"issue":"3","key":"B164-20261023","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1681\/ASN.2019050543","article-title":"Racial\/ethnic disparities in atrial fibrillation treatment and outcomes among dialysis patients in the United States","volume":"31","author":"Waddy","year":"2020","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B165-20261023","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2215\/CJN.03920319","article-title":"Racial and ethnic variations in mortality rates for patients undergoing maintenance dialysis treated in US territories compared with the US 50 States","volume":"15","author":"Yan","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"9","key":"B166-20261023","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1681\/ASN.2016010027","article-title":"Social determinants of racial disparities in CKD","volume":"27","author":"Norton","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B167-20261023","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2215\/CJN.14591218","article-title":"How community engagement is enhancing NIDDK research","volume":"14","author":"Kimmel","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3 suppl 3","key":"B168-20261023","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1053\/j.ajkd.2008.05.038","article-title":"The national kidney disease education program: improving understanding, detection, and management of CKD","volume":"53","author":"Narva","year":"2009","journal-title":"Am J Kidney Dis."},{"issue":"7 suppl 2","key":"B169-20261023","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/01.ASN.0000070156.78824.C7","article-title":"National kidney disease education program","volume":"14","author":"Hostetter","year":"2003","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B170-20261023","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2215\/CJN.02120217","article-title":"Complementary initiatives from the NIDDK to advance kidney health","volume":"12","author":"Norton","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B171-20261023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2215\/CJN.06570520","article-title":"Jump-starting kidney research: fostering disruptive innovation to advance nephrology","volume":"16","author":"Norton","year":"2021","journal-title":"Clin J Am Soc Nephrol."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:01:02Z","timestamp":1792771262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000906"}},"subtitle":["75 Years of Discovery and Impact"],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":165,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000906","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}